A Study of LY3041658 in Participants With Skin Diseases

NCT02896868 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases
Psoriasis

Interventions

DRUG: LY3041658
DRUG: Placebo

Sponsor

Eli Lilly and Company